ITERUM THERAPEUTICS PLC
Profile
Company Names
ITERUM THERAPEUTICS PLC
ITERUM THERAPEUTICS LTD
Addresses
BLOCK 2 FLOOR 3, HARCOURT CENTRE, HARCOURT STREET, DUBLIN, L2 2
BLK 2 FL. 3, HARCOURT CENTRE, HARCOUT ST, DUBLIN, L2 2
25-28 NORTH WALL QUAY, DUBLIN, L2 1
Phone Numbers
(872) 225-6077
(312) 778-6070
Entity Type:
CORPORATION
Industry:
PHARMACEUTICALS, BIOTECHNOLOGY
Year Incorporated:
2015
State Incorporated:
IRELAND
Total Amount Raised:
$183,002,713.00
Number of Funding Rounds:
5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2020-07-02
$2,832,102.00
$2,832,102.00
$0.00
4
2020-06-05
$2,844,627.00
$2,844,627.00
$0.00
3
2020-01-21
$51,588,000.00
$51,588,000.00
$0.00
Debt
2
2017-05-18
$78,097,985.00
$78,097,985.00
$0.00
Equity
1
2015-11-18
$47,639,999.00
$47,640,000.00
$1.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
BRENTON
K.
AHRENS
DIRECTOR
LOUISE
BARRETT
DIRECTOR, EXECUTIVE OFFICER
MARK
CHIN
DIRECTOR
OPTIKIRA, LLC
| ITERUM THERAPEUTICS LTD
| HARPOON THERAPEUTICS, INC.
| AURA BIOSCIENCES, INC.
| VELOSBIO INC.
| IMARA INC.
| ITERUM THERAPEUTICS BERMUDA LTD
| ITERUM THERAPEUTICS PLC
| ITERUM THERAPEUTICS US LTD
| ITERUM THERAPEUTICS US HOLDING LTD
| ITERUM THERAPEUTICS INTERNATIONAL LTD
| SORRISO PHARMACEUTICALS, INC.
| ENSOMA, INC.
| AVENZOAR PHARMACEUTICALS, INC.
MICHAEL
DUNNE
EXECUTIVE OFFICER, PROMOTER
COREY
N.
FISHMAN
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
JAMES
I.
HEALY
DIRECTOR
CEBIX INCOPRATED
| AMARIN CORP PLC\UK
| SORBENT THERAPEUTICS INC
| CEBIX INC
| HYPERION THERAPEUTICS INC
| ITERUM THERAPEUTICS LTD
| SOFINNOVA VENTURE PARTNERS X, L.P.
| ITERUM THERAPEUTICS BERMUDA LTD
| ITERUM THERAPEUTICS PLC
| ITERUM THERAPEUTICS US LTD
| ITERUM THERAPEUTICS US HOLDING LTD
| ITERUM THERAPEUTICS INTERNATIONAL LTD
| SEAPORT THERAPEUTICS, INC.
PATRICK
HERON
DIRECTOR
QUATRX PHARMACEUTICALS CO
| TRUBION PHARMACEUTICALS, INC
| COLLEGIUM PHARMACEUTICAL INC
| VENTIRX PHARMACEUTICALS INC
| TOBIRA THERAPEUTICS, INC.
| KALIDEX PHARMACEUTICALS, INC.
| PRECISION DERMATOLOGY, INC.
| INFORMED MEDICAL COMMUNICATIONS, INC.
| SILVERGATE PHARMACEUTICALS, INC.
| VENTIRX PHARMACEUTICALS INC.
| FRAZIER HEALTHCARE VII-A, L.P.
| FRAZIER HEALTHCARE VII, L.P.
| K2 THERAPEUTICS, INC.
| IMAGO BIOSCIENCES, INC.
| COLLEGIUM PHARMACEUTICAL, INC
| CIDARA THERAPEUTICS, INC.
| NEXCIDA THERAPEUTICS, INC.
| ITERUM THERAPEUTICS LTD
| ZAVANTE THERAPEUTICS, INC.
| SUTROVAX, INC.
| SCOUT BIO, INC.
| RECIDA THERAPEUTICS, INC.
| MIRUM PHARMACEUTICALS, INC.
| PASSAGE BIO, INC.
| ARCUTIS BIOTHERAPEUTICS, INC.
| MBX BIOSCIENCES, INC.
PATRICK
J.
HERON
DIRECTOR
FRAZIER LIFE SCIENCES VIII, L.P.
| FRAZIER HEALTHCARE GROWTH BUYOUT FUND VIII, L.P.
| FRAZIER HEALTHCARE GROWTH BUYOUT AFFILIATES VIII, L.P.
| ITERUM THERAPEUTICS LTD
| FRAZIER LIFE SCIENCES IX, L.P.
| FRAZIER HEALTHCARE GROWTH BUYOUT AFFILIATES IX, L.P.
| FRAZIER HEALTHCARE GROWTH BUYOUT FUND IX, L.P.
| FRAZIER HEALTHCARE GROWTH BUYOUT FUND IX PV, L.P.
| IMAGO BIOSCIENCES, INC.
| ITERUM THERAPEUTICS BERMUDA LTD
| ITERUM THERAPEUTICS PLC
| ITERUM THERAPEUTICS US LTD
| ITERUM THERAPEUTICS US HOLDING LTD
| ITERUM THERAPEUTICS INTERNATIONAL LTD
| MIRUM PHARMACEUTICALS, INC.
| FRAZIER LIFE SCIENCES XI, L.P.
ROBERT
HOPFNER
DIRECTOR
RONALD
M.
HUNT
DIRECTOR
DAVID
KELLY
DIRECTOR
TEXTURA CORP
| WHEELER REAL ESTATE INVESTMENT TRUST, INC.
| CHAKANA RESOURCES CORP
| INNOVASEA SYSTEMS, INC.
| AON PRIVATE CREDIT OPPORTUNITIES FUND, LLC
| ITERUM THERAPEUTICS BERMUDA LTD
| ITERUM THERAPEUTICS PLC
| ITERUM THERAPEUTICS US LTD
| ITERUM THERAPEUTICS US HOLDING LTD
| ITERUM THERAPEUTICS INTERNATIONAL LTD
| PEPE-S OF BROWARD, LLC
| CONCEPT NEIGHBORHOOD FUND I, LP
| TAPESTRY VC FUND II, LP
| SENSCY INC.
| INDUCTIVEMIND RESEARCH, LLC
| KPS LIFE HOLDCO, LLC
SHAHZAD
MALIK
DIRECTOR
CONATUS PHARMACEUTICALS INC
| PATHWORK DIAGNOSTICS INC
| VERSARTIS, INC.
| ACUTUS MEDICAL, INC.
| IDUN PHARMACEUTICALS INC
| ADVENT LIFE SCIENCES FUND II LP
| AGENUS INC
| NALU MEDICAL, INC.
| AXONICS MODULATION TECHNOLOGIES, INC.
| ITERUM THERAPEUTICS LTD
| ADVENT LIFE SCIENCES FUND III LP
| ITERUM THERAPEUTICS BERMUDA LTD
| ITERUM THERAPEUTICS PLC
| ITERUM THERAPEUTICS US LTD
| ITERUM THERAPEUTICS US HOLDING LTD
| ITERUM THERAPEUTICS INTERNATIONAL LTD
| ADVENT-HARRINGTON IMPACT FUND LP
| MOXIMED, INC
| ADVENT LIFE SCIENCES GROWTH FUND LP
JUDITH
M.
MATTHEWS
EXECUTIVE OFFICER, PROMOTER, DIRECTOR
TRACY
SAXTON
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2020-01-21
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2020-01-21
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2020-01-21
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2020-01-21
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2020-01-21
D/A
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2017-05-18
